【先声药业(02096.HK)拟8318.38万元收购上海祥瑞的全部资产及先为的全部股权 以快速切入mRNA技术领域】智通财经APP讯,先声药业(02096.HK)公布,于2025年8月26日,公司的间接全资附属公司海南先声拟向北京祥瑞收购上海祥瑞的全部资产及先为的全部股权,代价分别为1752.26万元及6566.12万元,总代价为8318.38万元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.